We will be holding our next regular monthly Philadelphia Multiple Myeloma Networking Group (PMMNG) meeting on Saturday, April 12, 2025 from 1:30-3:00 PM EST via Zoom.  Our meeting will feature a presentation about bone health in multiple myeloma by Dr. Matthew Drake.

Matthew T. Drake, MD, Ph.D, is a board certified Endocrinologist at the Hospital for Special Surgery in New York City and Chief of the Endocrinology and Metabolic Bone Disease Services where he provides care to patients with metabolic bone diseases, rare bone diseases, and cancers that affect the skeleton. He formerly served as Consultant and Associate Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, including as Chair of the Mayo Clinic Endocrinology Metabolic Bone Disease Group during the decade prior to his move to the Hospital for Special Surgery (HSS) in January 2025.

After receiving his AB degree from Harvard College, where he graduated magna cum laude, Dr. Drake completed his MD and PhD degrees in the Medical Scientist Training Program at Washington University in St. Louis. His clinical training in Internal Medicine was performed at Duke University Medical Center in Durham, North Carolina. He completed his Endocrinology fellowship training at Mayo Clinic in the Clinician-Investigator Pathway, joining the Mayo Clinic staff in 2007.

Dr. Drake has performed basic, translational, and clinical research under NIH-sponsored grants and has published over 130 articles in a variety of scientific journals including the Journal of Bone and Mineral Research, Bone, Nature Medicine, Lancet Diabetes and Endocrinology, JAMA, the Journal of Clinical Investigation, the Journal of Clinical Endocrinology and Metabolism, Osteoporosis International, Lancet Oncology, and Blood. His research focuses on understanding the mechanisms underlying age-associated bone loss and the skeletal microarchitectural changes that accompany this condition, as well as the basis by which monoclonal gammopathies (monoclonal gammopathy of undetermined significance/MGUS and multiple myeloma) induce bone loss and fractures.

While the meeting itself will begin at 1:30, we will be starting the Zoom at 1:00 pm for anyone interested in having a little more time to talk to one another informally or ask questions.

Please note that we are peers, not doctors. So please be sure and discuss anything you hear in the meeting that might change your own considerations regarding treatment or side effects with your own doctor(s).

All PMMNG members will receive a meeting invitation via email.  If you are new to the group or our meetings, contact Barbara Falkowitz (b[email protected]) to receive the meeting link. 

We look forward to seeing you on Zoom!

Note: Dr. Drake's slides are attached below. And a recording of Dr. Drake's presentation is here. (The passcode is 5b^n5xPS)